Construction and Preliminary Investigation of a Plasmid Containing a Novel Immunotoxin DT390-IL-18 Gene for the Prevention of Murine Experimental Autoimmune Encephalomyelitis
Authors:
- 1 May 2008
- journal article
- research article
- Published by SAGE Publications in DNA and Cell Biology
- Vol. 27 (5) , 279-285
Abstract
Experimental autoimmune encephalomyelitis (EAE) is a neuropathological animal model for multiple sclerosis. Antigen-presenting cells (APCs) expressing interleukin-18 receptor (IL-18R) were shown to be crucial in the beginning and progress of EAE. In this study we tested the effect of a novel recombinant immunotoxin targeting IL-18R–bearing APC for EAE prevention. The novel eukaryotic plasmid DT390-IL-18-SRα, encoding recombinant immunotoxin DT390-IL-18, was constructed. The immunotoxin consisted of IL-18 as the targeting moiety, and a truncated diphtheria toxin (DT) as the toxic moiety. Transfection assay and proliferation inhibition assay proved the immunotoxin could be expressed in vitro and was toxic to the activated mouse T cells. To evaluate the preventive effect of DT390-IL-18-SRα on EAE in vivo, cationic liposome-embedded DT390-IL-18-SRα was injected into the hind limbs of EAE mice. DT390-IL-18-SRα–treated mice showed a delayed manifestation of EAE and decreased symptoms compared to the mice treated with plasmid DT390-SRα or phosphate-buffered saline alone. A significant reduction in infiltrating inflammatory cells was detected in the brain tissues from immunotoxin-treated mice as compared with the controls by hematoxylin–eosin staining. This study suggested that the recombinant immunotoxin DT390-IL-18 could be expressed in vitro and in vivo, and prevented murine EAE effectively.Keywords
This publication has 28 references indexed in Scilit:
- Prevention of murine experimental autoimmune encephalomyelitis by in vivo expression of a novel recombinant immunotoxin DT390-RANTESGene Therapy, 2006
- Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisJournal of Clinical Investigation, 2006
- Pathophysiology of Interleukin-23 in Experimental Autoimmune EncephalomyelitisDrug News & Perspectives, 2006
- A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17Nature Immunology, 2005
- CEACAM6 as a novel target for indirect type 1 immunotoxin-based therapy in pancreatic adenocarcinomaBiochemical and Biophysical Research Communications, 2004
- The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damageCurrent Opinion in Neurology, 2003
- Interleukin-18Methods, 1999
- An Anti-CD3 Single-chain Immunotoxin with a Truncated Diphtheria Toxin Avoids Inhibition by Pre-existing Antibodies in Human BloodJournal of Biological Chemistry, 1995
- Genetic Construction of a Phosphorylation Site in Ricin A Chain: Specific Radiolabeling of Recombinant Proteins for Localization and Degradation StudiesBiochemical and Biophysical Research Communications, 1995
- Immunological Aspects of Experimental Allergic Encephalomyelitis and Multiple SclerosisCritical Reviews in Clinical Laboratory Sciences, 1995